[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Comment & Response
August 18, 2015

Inferior Vena Cava Filter and Recurrent Pulmonary Embolism—Reply

Author Affiliations
  • 1Service de Médecine Vasculaire et Thérapeutique, Centre Hospitalier Universitaire de Saint-Etienne, Saint-Etienne, France
  • 2Unité de Recherche Clinique, Innovation, Pharmacologie, Centre Hospitalier Universitaire de Saint-Etienne, Saint-Etienne, France
  • 3Université Paris Descartes, Sorbonne Paris Cité, Paris, France
JAMA. 2015;314(7):729-730. doi:10.1001/jama.2015.8012

In Reply We agree with Dr Hoffer’s comment emphasizing the long-term benefit of vena cava filter placement seen in the PREPIC study with regard to reducing the risk of recurrent pulmonary embolism.1,2 However, this beneficial effect was counterbalanced by an increased risk of lower-limb deep venous thrombosis, including filter thromboses, even though 50% of the patients were still receiving anticoagulant treatment.2 Thus, vena cava filters were not associated with a decrease in the overall long-term risk of recurrent venous thromboembolism in the PREPIC study.